EUVIMEDEUVIMED entdecken
Open Access

Intravenous to Oral Antibiotic Switch Therapy Among Patients Hospitalized With Community-Acquired Pneumonia

Abhishek Deshpande iD, Michael Klompas, Ning Guo, Peter B Imrey, Andrea M Pallotta, Thomas Higgins, Sarah Haessler, Marya D Zilberberg, Peter K Lindenauer, Michael B Rothberg

Clinical Infectious Diseases · 26.07.2023 · 77 (2) · 174-185

DOI: 10.1093/cid/ciad196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 03.04.2023. Verfasst von Abhishek Deshpande und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Value-Based Care Research, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Pneumonia, Community-Acquired Infections. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: AHRQ HHS, Agency for Healthcare Research and Quality, Cleveland Clinic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Community-acquired pneumonia (CAP) is a leading cause of hospital admissions and antimicrobial use. Clinical practice guidelines recommend switching from intravenous (IV) to oral antibiotics once patients are clinically stable.

Methods

We conducted a retrospective cohort study of adults admitted with CAP and initially treated with IV antibiotics at 642 US hospitals from 2010 through 2015. Switching was defined as discontinuation of IV and initiation of oral antibiotics without interrupting therapy. Patients switched by hospital day 3 were considered early switchers. We compared length of stay (LOS), in-hospital 14-day mortality, late deterioration (intensive care unit [ICU] transfer), and hospital costs between early switchers and others, controlling for hospital characteristics, patient demographics, comorbidities, initial treatments, and predicted mortality.

Results

Of 378 041 CAP patients, 21 784 (6%) were switched early, most frequently to fluoroquinolones. Patients switched early had fewer days on IV antibiotics, shorter duration of inpatient antibiotic treatment, shorter LOS, and lower hospitalization costs, but no significant excesses in 14-day in-hospital mortality or late ICU admission. Patients at a higher mortality risk were less likely to be switched. However, even in hospitals with relatively high switch rates, <15% of very low–risk patients were switched early.

Conclusions

Although early switching was not associated with worse outcomes and was associated with shorter LOS and fewer days on antibiotics, it occurred infrequently. Even in hospitals with high switch rates, <15% of very low–risk patients were switched early. Our findings suggest that many more patients could be switched early without compromising outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PneumoniaCommunity-Acquired InfectionsAdultHumansRetrospective StudiesAnti-Bacterial AgentsHospitalizationLength of StayAdministration, Oral

Stichwörter der Autor:innen

IV to oralantimicrobial stewardshipcommunity-acquired pneumoniaswitch therapy

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Center for Value-Based Care Research, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Infectious Disease, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
  • Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.

ORCID-Profile: Abhishek Deshpande

Förderung

  • AHRQ HHS
  • Agency for Healthcare Research and Quality
  • Cleveland Clinic

Zitieren

APA

Deshpande, A., Klompas, M., Guo, N., Imrey, P. B., Pallotta, A. M., Higgins, T., Haessler, S., Zilberberg, M. D., Lindenauer, P. K., & Rothberg, M. B. (2023). Intravenous to Oral Antibiotic Switch Therapy Among Patients Hospitalized With Community-Acquired Pneumonia. Clinical Infectious Diseases, 77(2), 174-185. https://doi.org/10.1093/cid/ciad196

Vancouver

Deshpande A, Klompas M, Guo N, Imrey PB, Pallotta AM, Higgins T, et al. Intravenous to Oral Antibiotic Switch Therapy Among Patients Hospitalized With Community-Acquired Pneumonia. Clinical Infectious Diseases. 2023;77(2):174-185. doi:10.1093/cid/ciad196

BibTeX
@article{Deshpande2023,
  author = {Deshpande, Abhishek and Klompas, Michael and Guo, Ning and Imrey, Peter B and Pallotta, Andrea M and Higgins, Thomas and Haessler, Sarah and Zilberberg, Marya D and Lindenauer, Peter K and Rothberg, Michael B},
  title = {Intravenous to Oral Antibiotic Switch Therapy Among Patients Hospitalized With Community-Acquired Pneumonia},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {77},
  number = {2},
  pages = {174--185},
  doi = {10.1093/cid/ciad196}
}
Kostenlos starten →